Yosuke Minami

16PUBLICATIONS

66CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCell and nuclear divisionPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 18, 2026

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Jun 11, 2026

Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 29, 2026

Population-Based Identification of Clonal Hematopoiesis Using Peripheral Blood Whole-Genome Sequencing in Japan.

|Mar 31, 2026

Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study.

Fumiya Ogasawara, Yosuke Minami, SungGi Chi

|May 07, 2025

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.

Michael J Mauro, Yosuke Minami, Andreas Hochhaus

|Dec 16, 2024

A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02.

Hironori Arai, Naoko Hosono, SungGi Chi

Pageof 3

Frequent Collaborators

Naoto Takahashi

Takaaki Ono

Michael J Mauro

Noriyoshi Iriyama

SungGi Chi

Yoshiko Atsuta

Emiko Sakaida

Shigeki Ohtake

Andreas Hochhaus

Itaru Matsumura

Frequent Collaborators

Naoto Takahashi

Takaaki Ono

Michael J Mauro

Noriyoshi Iriyama